4//SEC Filing
Papkoff Jacqueline Sybil 4
Accession 0001209191-20-021800
CIK 0001426800other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:16 PM ET
Size
9.9 KB
Accession
0001209191-20-021800
Insider Transaction Report
Form 4
Papkoff Jacqueline Sybil
See Remarks
Transactions
- Award
Common Stock
2020-03-27+17,000→ 39,915 total - Award
Common Stock (right to buy)
2020-03-27+34,000→ 34,000 totalExercise: $14.45Exp: 2030-03-27→ Common Stock (34,000 underlying) - Sale
Common Stock
2020-03-30$14.22/sh−1,254$17,831→ 38,661 total
Footnotes (4)
- [F1]Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2021; March 29, 2022; March 29, 2023; and March 29, 2024.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.05 to $14.79, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- [F4]Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on March 29, 2021; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2024.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001735729
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:16 PM ET
- Size
- 9.9 KB